On December 27, Glonghui reported that Yixintang Pharmaceutical (002727.SZ) announced that it would hold the seventh extraordinary meeting of the sixth Board of Directors on December 26, 2024, to discuss and approve the proposal regarding the investment by its wholly-owned subsidiary Guizhou Hongxiang Yixintang Pharmaceutical Chain Co., Ltd. to acquire land use rights and its attached properties. It was agreed that Guizhou Hongxiang Yixintang Pharmaceutical Chain Co., Ltd. (referred to as 'Guizhou Yixintang') would invest 32.8 million yuan of its own funds to acquire the land use rights and attached properties of the land parcel No. 13, split from the food industrial park Area A in Longdongbao, Nanming District, Guiyang City, owned by Guizhou Fanghong Industrial Co., Ltd. (referred to as 'Guizhou Fanghong').
一心堂(002727.SZ)：贵州一心堂以3280万元投资取得相关土地使用权及其地上附着物
Yixintang Pharmaceutical (002727.SZ): Guizhou Yixintang invested 32.8 million yuan to acquire the relevant land use rights and the attached structures on it.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated